Diametric Capital’s Soleno Therapeutics SLNO Stock Holding History

Diametric Capital’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-57,832	Closed	-$1.94M	–	668
2026 Q1	$1.94M	Buy	57,832 +26,504	+85%	+$1.04M	0.5%	36
2025 Q4	$1.45M	Buy	31,328 +23,867	+320%	+$1.31M	0.39%	59
2025 Q3	$504K	Buy	+7,461	New	+$553K	0.19%	147

Diametric Capital's SLNO Position: Q2 2026 in Review

Diametric Capital sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 57,832 shares — an estimated $1.94M sold.

Diametric Capital first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $1.94M in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Diametric Capital reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Diametric Capital sold 57,832 Soleno Therapeutics shares in Q2 2026, an estimated $1.94M.
Diametric Capital first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
Diametric Capital's Soleno Therapeutics position peaked at $1.94M in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.